Finance

Lists
ELVN:NASDAQ
Enliven Therapeutics Inc
40,98 USD
+0,86%
(+0,35) 1D
40,98 USD
0,00% (0,00)
After hours
Closed: 9-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELVN...
Open
41,00 USD
High
42,06 USD
Low
40,29 USD
Mkt. cap
3,00 млд
Avg. vol.
1,37 млн
Volume
1,00 млн
52-wk high
62,32 USD
52-wk low
14,78 USD
EPS
-1,67 USD
Beta
0,24
Shares outstanding
73,27 млн
No. of employees
67
Open
41,00 USD
High
42,06 USD
Low
40,29 USD
Mkt. cap
3,00 млд
Avg. vol.
1,37 млн
Volume
1,00 млн
52-wk high
62,32 USD
52-wk low
14,78 USD
EPS
-1,67 USD
Beta
0,24
Shares outstanding
73,27 млн
No. of employees
67
News stories
From web sources and news partners
About Enliven Therapeutics Inc
CEO-
Employees67
Founded2016
HeadquartersБоулдер, Колорадо, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websiteimaratx.com
Analyst ratings
Based on 13 analysts giving stock ratings to ELVN in the past 3 months
Strong buy
Buy
13
Hold
0
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for ELVN in the last 3 months.
Highest
Current 40,98 USD
82,00 USD (+100,10%)
Average
74,45 USD (+81,67%)
Lowest
68,00 USD (+65,93%)
Analyst
Recommendation
Action
Price target
Projected
Date
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
10/07/2026
Etzer Darout
Barclays
Buy
Maintained
78,00 USD
+90,3%
10/07/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
10/06/2026
Sean Laaman
Morgan Stanley
Buy
Initiated
70,00 USD
+70,8%
10/05/2026
Priyanka Grover
J.P. Morgan
Buy
Initiated
75,00 USD
+83%
10/01/2026
Salim Syed
Mizuho Securities
Buy
Maintained
73,00 USD
+78,1%
08/17/2026
Dara Azar
Stifel Nicolaus
Buy
Reiterated
82,00 USD
+100,1%
08/13/2026
Sam Slutsky
LifeSci Capital
Buy
Reiterated
70,00 USD
+70,8%
08/08/2026
Colleen M. Kusy
Robert W. Baird
Buy
Maintained
75,00 USD
+83%
08/06/2026
Boris Peaker
JonesTrading
Buy
Reiterated
70,00 USD
+70,8%
08/06/2026
Michael Schmidt
Guggenheim
Buy
Maintained
78,00 USD
+90,3%
08/05/2026
Salveen Richter
Goldman Sachs
Buy
Reiterated
80,00 USD
+95,2%
08/05/2026
Kaveri Pohlman
Clear Street
Buy
Reiterated
68,00 USD
+65,9%
08/06/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
65,00 USD
+58,6%
07/09/2026
Unknown Analyst
Jefferies
Buy
Maintained
59,00 USD
+44%
06/15/2026
Soumit Roy
JonesTrading
Buy
Maintained
45,00 USD
+9,8%
04/06/2026
Last report
2026-ж., 5-авг.
Fiscal period
Q2 2026
-0,49 USD / -0,38 USD
-29,80%miss
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
18,22 млн
21,24 млн
20,69 млн
29,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,87 млн
13,04 млн
7,14 млн
8,21 млн
Operating expense
25,10 млн
34,28 млн
27,82 млн
37,21 млн
Total operating expenses
25,10 млн
34,28 млн
27,82 млн
37,21 млн
Operating income
-25,10 млн
-34,28 млн
-27,82 млн
-37,21 млн
Other non operating income
-
-
-
-8,00 миң
EBT including unusual items
-20,15 млн
-29,67 млн
-23,63 млн
-32,48 млн
EBT excluding unusual items
-20,15 млн
-29,67 млн
-23,63 млн
-32,48 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20,15 млн
-29,67 млн
-23,63 млн
-32,48 млн
Net profit margin
-
-
-
-
Earnings per share
-0,32
-0,48
-0,38
-0,49
Interest and investment income
4,95 млн
4,62 млн
4,20 млн
4,73 млн
Interest expense
-
-
-
-
Net interest expenses
4,95 млн
4,62 млн
4,20 млн
4,73 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-25,03 млн
-34,24 млн
-27,81 млн
-37,20 млн
Gain or loss from assets sale
-
106,00 миң
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору